The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
about
Matrix Metalloproteinases in Non-Neoplastic Disorders.Protease inhibition as new therapeutic strategy for GI diseasesAngiogenesis in Inflammatory Bowel DiseaseThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerMatrix metalloproteinases in inflammatory bowel disease: an updateMedical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitisMatrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseasesMechanical Strain Induced Expression of Matrix Metalloproteinase-9 via Stretch-Activated Channels in Rat Abdominal Aortic Dissection.Inflammatory pathways in the early steps of colorectal cancer development.Impact of proteolytic enzymes in colorectal cancer development and progression.Mechanisms of initiation and progression of intestinal fibrosis in IBD.Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Resolution of inflammation pathways in preeclampsia-a narrative review.Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4+ T Lymphocyte Depletion in Treated HIV Infection.Role of matrix metalloproteinases and their inhibitor in the development of early pulmonary fibrosis in mice infected with influenza A/H5N1 A/goose/Krasnoozerskoye/627/05 virus.Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models.Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway.Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.Role of vitamin D derivatives in intestinal tissue of patients with inflammatory bowel diseases.
P2860
Q26741827-24DBC6F5-09BD-4BBD-A54C-BEDB8FAA0DA9Q26747722-B0806219-D5CA-4B4E-89DC-1DC6046BE5F9Q26769945-E1AB6A2F-8010-4C6A-BAB2-849AAA449593Q27004958-9FF86111-3290-46D8-83EC-7B3F40C7B6BFQ28080664-C6850CFA-AB7F-4215-8F97-5EA5BC8C0159Q34504710-5C92E40F-0A70-4CD3-AD58-0C6BB746F3C8Q35147482-7A8D58A8-38A1-4946-A3DF-610CAC178385Q36282521-8B33416E-3FEA-4209-876E-758CD2478AF5Q36382078-ECD3E943-020E-43DD-909A-1D52744B090DQ37706103-C30A2EEE-2572-44C9-9EAF-A7BD970B1F8FQ37716164-5DC64BD2-86AF-47E1-A94C-E8234DED7B9AQ38238739-D9C79533-B5C3-48ED-BA66-FBDDC5BFF2CAQ38259533-5A3B8486-2F8F-448D-9665-8112DF16E8C2Q38293779-0C3CA729-03E0-46FE-8D55-76E8A29C884DQ38935787-75F520F1-5563-47C3-A27A-2FB2CCCA52FFQ38950036-E3B01B05-4AD6-44F2-A6A6-FF8516ECE53EQ39229350-CCD5AB03-2A68-485E-810F-1AF865AB176FQ40104569-EC5DA2C4-D3A2-4B22-8809-4743E05D0731Q42250258-4027FAFB-9F53-4466-80F0-3447B5F54CD9Q43203577-CABCDB64-40CB-40EF-A149-33728CBA7EFFQ43551236-391794D8-8F7C-49AC-8080-8823FEC0921BQ46319948-79AE548C-40F2-45E3-A597-EB7085692CC9Q47127174-596044D1-086B-42BA-8719-398573F49AF4Q47258530-F7F0DA82-79F7-429C-AD53-9B2D8273BB1CQ47889885-71F9FA61-AE62-4C17-B710-DD3DF8A2A8A7Q49106201-B3BDC21A-69A5-4AAF-9E2D-EE02146FD3F9Q50986872-B8EA783C-882F-4F5B-8EE3-65E74F824D50Q51066069-0AF851ED-1E01-4662-83BD-EC53A4ED9B89Q53062489-BE9BBC2A-CF0B-47CB-BC8A-9872437D1C4C
P2860
The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
description
scientific article published on 20 June 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2012
@uk
name
The Impact of Matrix Metallopr ...... in Inflammatory Bowel Diseases
@en
The Impact of Matrix Metallopr ...... in Inflammatory Bowel Diseases
@nl
type
label
The Impact of Matrix Metallopr ...... in Inflammatory Bowel Diseases
@en
The Impact of Matrix Metallopr ...... in Inflammatory Bowel Diseases
@nl
prefLabel
The Impact of Matrix Metallopr ...... in Inflammatory Bowel Diseases
@en
The Impact of Matrix Metallopr ...... in Inflammatory Bowel Diseases
@nl
P2093
P2860
P356
P1433
P1476
The impact of matrix metallopr ...... in inflammatory bowel diseases
@en
P2093
Gabriel Cierny
Gábor Lakatos
László Herszényi
Mária Zsófia Varga
Márk Juhász
Pál Miheller
Zsolt Tulassay
P2860
P304
P356
10.1159/000336995
P50
P577
2012-06-20T00:00:00Z